BLKBRD Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.12M Sell
57,664
-9,880
-15% -$468K 5.54% 12
2025
Q4
$3.44M Sell
67,544
-211,470
-76% -$10.8M 4.62% 15
2025
Q3
$15.5M Buy
+279,014
New +$16.3M 4.31% 16

Other funds holding NVO

BLKBRD Asset Management's NVO Position: Q1 2026 in Review

BLKBRD Asset Management reduced its Novo Nordisk (NVO) stake by 15% in Q1 2026, selling an estimated $468K and leaving 57,664 shares worth $2.12M. The position accounts for 5.54% of the portfolio, ranked #12.

BLKBRD Asset Management first reported a position in NVO in Q3 2025 and has held it in 3 quarters since. The position peaked at $15.5M in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • BLKBRD Asset Management held 57,664 shares of Novo Nordisk worth $2.12M as of Q1 2026.
  • BLKBRD Asset Management sold 9,880 Novo Nordisk shares in Q1 2026, an estimated $468K.
  • Novo Nordisk made up 5.54% of BLKBRD Asset Management's portfolio in Q1 2026, its #12 holding.
  • BLKBRD Asset Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 3 quarters since.
  • BLKBRD Asset Management's Novo Nordisk position peaked at $15.5M in Q3 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on BLKBRD Asset Management's 13F filing for Q1 2026, filed 15 May 2026.